You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm said it intends to use the credit facility to support its US and European commercial paper programs and for general corporate purposes.
Bio-Techne said pathologists now have access to its fully automated RNAscope technology, providing them with a new tool to evaluate disease biomarkers.
The award amount is about $2.3 million, BARDA said, while a Beckman Coulter spokesperson added the full contract is valued at up to $8.06 million.
News items for in vitro diagnostics industry for the week of May 11, 2020.
Only 2.5 percent of Americans have been tested for COVID-19, even as industry scrambles to increase testing capacity and a second wave of cases may hit in the fall.
The firm said it would use the funds for general corporate purposes, including potential future acquisitions, capital expenditures, and investments or loans.
Danaher President and CEO Thomas Joyce will retire in September and will be replaced by Rainer Blair, the current executive VP of the life sciences division.
News items for the in vitro diagnostics industry for the week of April 27, 2020.
The company noted a slowdown in demand in instrument-oriented businesses toward the end of the first quarter due to the COVID-19 pandemic.